Summary
Global Markets Direct’s, ‘Bharat Biotech International Limited - Product Pipeline Review - 2016’, provides an overview of the Bharat Biotech International Limited’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Bharat Biotech International Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
Scope
- The report provides a snapshot of the pipeline therapeutic landscape of Bharat Biotech International Limited
- The report provides overview of Bharat Biotech International Limited including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Bharat Biotech International Limited’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Bharat Biotech International Limited’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Bharat Biotech International Limited’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Bharat Biotech International Limited
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Bharat Biotech International Limited’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
'
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Bharat Biotech International Limited Snapshot 6
Bharat Biotech International Limited Overview 6
Key Information 6
Key Facts 6
Bharat Biotech International Limited - Research and Development Overview 7
Key Therapeutic Areas 7
Bharat Biotech International Limited - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Bharat Biotech International Limited - Pipeline Products Glance 12
Bharat Biotech International Limited - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Bharat Biotech International Limited - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Bharat Biotech International Limited - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
Bharat Biotech International Limited - Drug Profiles 16
THR-100 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
lysostaphin 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
chikungunya vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
human serum albumin (recombinant) 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
malaria vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Salmonella [serotypes typhimurium, enteritidis] vaccine 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Staphylococcus aureus vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Zika virus vaccine 1 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
human papillomavirus vaccine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
pertussis (acellular) vaccine 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
polio vaccine 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Salmonella paratyphi vaccine 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
tetanus vaccine 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
Zika virus vaccine 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Bharat Biotech International Limited - Pipeline Analysis 31
Bharat Biotech International Limited - Pipeline Products by Target 31
Bharat Biotech International Limited - Pipeline Products by Route of Administration 32
Bharat Biotech International Limited - Pipeline Products by Molecule Type 33
Bharat Biotech International Limited - Pipeline Products by Mechanism of Action 34
Bharat Biotech International Limited - Recent Pipeline Updates 35
Bharat Biotech International Limited - Dormant Projects 36
Bharat Biotech International Limited - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 38
Disclaimer 39
List of Tables
Bharat Biotech International Limited, Key Information 6
Bharat Biotech International Limited, Key Facts 6
Bharat Biotech International Limited - Pipeline by Indication, 2016 9
Bharat Biotech International Limited - Pipeline by Stage of Development, 2016 10
Bharat Biotech International Limited - Monotherapy Products in Pipeline, 2016 11
Bharat Biotech International Limited - Phase III, 2016 12
Bharat Biotech International Limited - Phase II, 2016 13
Bharat Biotech International Limited - Preclinical, 2016 14
Bharat Biotech International Limited - Discovery, 2016 15
Bharat Biotech International Limited - Pipeline by Target, 2016 31
Bharat Biotech International Limited - Pipeline by Route of Administration, 2016 32
Bharat Biotech International Limited - Pipeline by Molecule Type, 2016 33
Bharat Biotech International Limited - Pipeline Products by Mechanism of Action, 2016 34
Bharat Biotech International Limited - Recent Pipeline Updates, 2016 35
Bharat Biotech International Limited - Dormant Developmental Projects,2016 36
List of Figures
Bharat Biotech International Limited - Pipeline by Top 10 Indication, 2016 8
Bharat Biotech International Limited - Pipeline by Stage of Development, 2016 10
Bharat Biotech International Limited - Monotherapy Products in Pipeline, 2016 11
Bharat Biotech International Limited - Pipeline by Target, 2016 31
Bharat Biotech International Limited - Pipeline by Route of Administration, 2016 32
Bharat Biotech International Limited - Pipeline by Molecule Type, 2016 33
Bharat Biotech International Limited - Pipeline Products by Mechanism of Action, 2016 34
